Hongjie Chen
About Hongjie Chen
Hongjie Chen is a scientist specializing in genetic epidemiology, currently working at Tessera Therapeutics since 2021. He has an extensive background in epidemiology, having held various research and analytical roles in academia and industry.
Work at Tessera Therapeutics
Currently, Hongjie Chen serves as a Scientist in Genetic Epidemiology at Tessera Therapeutics, a position held since 2021. In this role, he leads systematic literature reviews and data analysis to estimate epidemiology parameters and potential market size for drug discovery. Additionally, he analyzes causative genetic variants to interpret the genetic landscape of therapeutic targets, contributing to the company's research and development efforts in genetic medicine.
Previous Experience in Genetic Epidemiology
Prior to his current role, Hongjie Chen worked as a Postdoctoral Scholar at the Keck School of Medicine of the University of Southern California from 2020 to 2021. He also held the position of Epidemiologist at the Alabama Medicaid Agency for eight months in 2015-2016. His experience includes conducting research and analysis in various public health settings, enhancing his expertise in genetic epidemiology.
Education and Expertise
Hongjie Chen earned his Doctor of Philosophy (PhD) in Epidemiology from the University of Washington, where he studied from 2016 to 2020. He also holds a Master of Public Health (MPH) in Epidemiology from Emory University, completed between 2013 and 2015. His academic background is further supported by a Bachelor of Engineering (BE) in Pharmaceutical Science from East China University of Science and Technology, obtained from 2009 to 2013.
Internship Experience at GSK
In 2019, Hongjie Chen completed a two-month summer internship at GSK in Collegeville, Pennsylvania. This experience provided him with exposure to the pharmaceutical industry and contributed to his professional development in the field of genetic epidemiology.
Research Assistant Role
Hongjie Chen began his research career as a Research Assistant at the Shanghai Institutes for Biological Sciences from 2012 to 2013. This role allowed him to engage in scientific research early in his career and laid the foundation for his future studies and professional pursuits in epidemiology.